22 Quotes by Ryan Bethencourt

We're at the beginning of the digitization and automation of biotech.

The success stories in biotechnology are mainly due to the straightforward application of design thinking in both the business and science aspects of our lean startups.

When deciding whether to fund and build a company, we start from basic principles and because many of the businesses and products that our companies create are a complete novelty to us, them and the market, we have to do the math.

I believe within five to 10 years most larger corporations will switch to greener industrial enzymes, not just for the environment but also for their bottom line.

Biology is greener and, at scale, should be incredibly cost-effective: The cost of goods sold should be little more than the sugar water needed to brew almost anything.

We're starting to see a renaissance of investors embracing the idea that scientists can build businesses.

I imagine a day, some time in the not too distant future when children and teenagers will be able to create their own genetically engineered machines, cure the diseases of the old and find new ways to build and extend the capabilities of humanity, moving from programming software to programing the physical world, through biology.

Biohackers want to tinker; do fun science; and, in the process, accelerate the pace of biotech innovation.

IndieBio's capital, facilities and deep mentoring by a network of biotech specific experts have the potential to spawn the Google's, Facebook's and Instagram's of biology.